Navigation Links
ACE Inhibitors For Vascular Disease Patients

Researchers at the Laval University Heart and Lung Institute in Quebec have found that drugs used to treat heart failure also reduced the risk of death, heart attacks// and stroke in people with hardened arteries and hence should be considered in all vascular disease patients.

ACE inhibitors are drugs that lower blood pressure by inhibiting the formation of a chemical that causes arteries in the body to constrict. They are used to treat heart failure.

In an analysis of three major studies, they found that two out of the three studies involving nearly 30,000 people clearly showed such a benefit. The two studies that showed benefits looked at the incidence of heart attacks, stroke and overall deaths from heart disease, while the third study also looked at the incidence of procedures such as angioplasty in patients with atherosclerosis.

Kim Fox, a professor of clinical cardiology at Royal Brompton Hospital in London and a co-author of the report said that ACE inhibitors should be considered in all vascular disease patients.

Dr. Gilles R. Dagenais, a member of the research team said ACE inhibitors should be prescribed "for patients who have coronary heart disease and also atherosclerosis in major arteries, such as those in the brain, if there are no contraindications and if the physician judges there is benefit.”

However, two Italian Cardiologist have argued against the use of ACE inhibitors in such cases pointing to the results of the third study, which was not favorable.

Though the use of ACE inhibitors to reduce risk of vascular disease is debatable, Dr. Gary Francis, Head of the Cleveland Clinic Clinical cardiology section said that the Canadian interpretation was probably correct as it was done by a group highly qualified to do such studies.

Francis said, but "like all meta-analyses, it has some problems. It would be naive to believe that a meta-analysis would have power ov er a randomized, controlled study,"

He also said still "I have a low threshold to go to ACE inhibitors because there is a low price to pay for their benefits. They should be considered for all patients with atherosclerosis.”


'"/>




Related medicine news :

1. Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
2. LipB Protein Inhibitors Help To Fight Against TB
3. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
4. Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer
5. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
6. Drug Effective for Vascular Dementia
7. New Ways To Treat Vascular Birthmarks
8. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
9. Blood Clots, A Common Feature Of Vascular Dementia And Alzheimers
10. Vascular Disease 101: Discovering and Treating Common Diseases of the Veins
11. People Under 60 At Risk Of Premature Peripheral Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Gym Source, ... of a new showroom at South Dixie Hwy in Miami, FL. , “We are ... Gym Source. “The new innovative in-store concept is designed to give clients a seamless ...
(Date:1/17/2017)... Los Angeles, CA (PRWEB) , ... January 17, ... ... conflicted and concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting ... tragedies and magical moments that help everyone endure and pass through tough times, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of the original Sharks ... DRTV campaigns regarding the topic of Beauty and Personal Care. , ... What better way to commit to these changes than beginning with personal care and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with multiple ... new office in San Clemente, California this month. Achieve TMS West is the ... treating individuals struggling with major depression. Depression impacts over 15 million adults in ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased to ... on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more ... addition to our provider network, and the addition will benefit our members in ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... pharmaceutical development at Tocagen, will present at Phacilitate Cell & ... Miami . Details of the ... ... - what to do when and why Date and Time: Wednesday, ...
(Date:1/17/2017)... 2017 Research and Markets has announced the ... Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug ... 2021" report to their offering. ... The global active pharmaceutical ingredients market is ... Billion in 2016, growing at a CAGR of 6.3% from 2016 ...
Breaking Medicine Technology: